FDA — authorised 6 August 1986
- Marketing authorisation holder: CHESEBROUGH PONDS
- Status: approved
FDA authorised SODIUM MONOFLUOROPHOSPHATE on 6 August 1986
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 6 August 1986.
CHESEBROUGH PONDS holds the US marketing authorisation.